[1] Raul JA,Naga C,Einar SB,et al.Drug- induced liver injury.Nat Rev Dis Primers,2019,22,5:58. [2] Zhou Y,Yang L,Liao Z,et al.Epidemiology of drug-induced liver injury in China:a systematic analysis of the Chinese literature including 21,789 patients.Eur J Gastroenterol Hepatol,2013,25:825-9. [3] Shen T,Liu Y,Shang J,et al.Incidence and etiology of drug-induced liver injury in Mainland China.Gastroenterology,2019,156:2230-2241. [4] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南.临床肝胆病杂志,2015,31:1752-1769. [5] Danan G,Benichou C.Causality assessment of adverse reactions to drugs—I.A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries.J Clin Epidemiol,1993,46:1323-1330. [6] Benichou,Danan G,Flahault A.Causality assessment of adverse reactions to drugs—II.An original model for validation of drug causality assessment methods:case reports with positive rechallenge.J Clin Epidemiol,1993,46:1331-1336. [7] Leise MD,Poterucha JJ,Talwalkar JA.Drug-induced liver injury.Mayo Clin Proc,2014,89:95-106. [8] Navarro VJ,Senior JR.Drug-related hepatotoxicity.N Engl J Med,2006,354:731-739. [9] Ou P,Chen Y,Li B,et al.Causes,clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital.Springerplus,2015,22:802. [10] Zhu CW,Wang HN,Yuan JL,et.Clinical features of drug induced liver injury:an analysis of 445 cases.J Clin Hepato (临床肝胆病杂志),2018,34:354-358. [11] European Association for the Study of the Liver.EASL clinical practice guidelines:drug-induced liver injury.J Hepatol,2019,70:1222-1261. [12] Chalasani NP,Hayashi PH,Bonkovsky HL,et al.ACG clinical guideline:the diagnosis and management of idiosyncratic drug-induced liver injury.Am J Gastroenterol,2014,109:950-66. [13] Raul J Andrade,Inmaculada Medina-Caliz,Andres Gonzalez-Jimenez,et al.Hepatic damage by natural remedies.Semin Liver Dis,2018,38:021-40. [14] 黄春洋,单晶,廖慧钰,等.甲基强的松龙治疗药物性肝损伤患者临床及实验室特点分析.实用肝脏病杂志,2019,22:208-211. |